Clinical Trials Browser

Resectable Pancreatic Cancer × folfirinox × 90 days × Clear all

NCT04472910 2026-03-12

NeoPancOne

Phase NA Active not recruiting

Gastrointestinal

Resectable Pancreatic Cancer